Literature DB >> 24935413

Posterior cerebral artery stroke presenting as alexia without agraphia.

Bhawna Sharma1, Rahul Handa2, Swayam Prakash1, Kadam Nagpal1, Indu Bhana1, Pankaj Kumar Gupta1, Sunil Kumar1, Mahendra Singh Sisodiya1.   

Abstract

Alexia without agraphia (pure alexia) was the first of the disconnection syndromes to be described by Dejerine who reported a patient of alexia without agraphia secondary to an embolic occipital lobe infarct. We herein report a 55-year-old man who presented with alexia without agraphia with magnetic resonance imaging suggestive of left posterior cerebral artery infarct involving left occipital lobe and splenium of corpus callosum. Alexia without agraphia is a relatively uncommon clinical condition, which should always be thought in a patient presenting with difficulty in reading with normal visual acuity. Ophthalmologists should also be aware of this disconnection syndrome as many patients initially take their advice due to predominant visual complaints. Early diagnosis and treatment of this condition help in ensuring the patient and attendants about nonprogressive nature of the disease and may prevent further episodes of stroke.

Entities:  

Mesh:

Year:  2014        PMID: 24935413     DOI: 10.1016/j.ajem.2014.04.046

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  3 in total

1.  Alexia Without Agraphia: A Rare Entity.

Authors:  Chintan Rupareliya; Syeda Naqvi; Seyedali Hejazi
Journal:  Cureus       Date:  2017-06-02

2.  Infarction of the corpus callosum: a retrospective clinical investigation.

Authors:  Shen Li; Xin Sun; Yu-meng Bai; Hua-min Qin; Xiao-mei Wu; Xiao Zhang; Jukka Jolkkonen; Johannes Boltze; Su-ping Wang
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

3.  From Schools to Scans: A Neuroeducational Approach to Comorbid Math and Reading Disabilities.

Authors:  Jeremy G Grant; Linda S Siegel; Amedeo D'Angiulli
Journal:  Front Public Health       Date:  2020-10-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.